BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23002205)

  • 1. Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma.
    Wan X; Yeung C; Kim SY; Dolan JG; Ngo VN; Burkett S; Khan J; Staudt LM; Helman LJ
    Cancer Res; 2012 Nov; 72(22):5889-99. PubMed ID: 23002205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma.
    Ma Q; Liu Y; Shang L; Yu J; Qu Q
    Oncol Rep; 2017 Dec; 38(6):3367-3375. PubMed ID: 29039578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.
    Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
    J Biol Chem; 2008 Jan; 283(1):453-460. PubMed ID: 17984092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
    Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box M1 is regulated by heat shock factor 1 and promotes glioma cells survival under heat shock stress.
    Dai B; Gong A; Jing Z; Aldape KD; Kang SH; Sawaya R; Huang S
    J Biol Chem; 2013 Jan; 288(3):1634-42. PubMed ID: 23192351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
    Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
    Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
    Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA.
    Wang M; Gartel AL
    Oncotarget; 2011 Dec; 2(12):1218-26. PubMed ID: 22203467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects and molecular mechanisms of inhibiting FOXM1 expression on ovarian cancer cell line SKOV3 by Lentiviral vector].
    Chen GQ; Yao ZW; Qi HB; Zhang H; Luo Y; Qin XF
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):29-32. PubMed ID: 22230500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents.
    Komura K; Inamoto T; Tsujino T; Matsui Y; Konuma T; Nishimura K; Uchimoto T; Tsutsumi T; Matsunaga T; Maenosono R; Yoshikawa Y; Taniguchi K; Tanaka T; Uehara H; Hirata K; Hirano H; Nomi H; Hirose Y; Ono F; Azuma H
    Oncogene; 2021 Oct; 40(43):6210-6222. PubMed ID: 34545188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chk2 mediates stabilization of the FoxM1 transcription factor to stimulate expression of DNA repair genes.
    Tan Y; Raychaudhuri P; Costa RH
    Mol Cell Biol; 2007 Feb; 27(3):1007-16. PubMed ID: 17101782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
    Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
    Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
    Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21
    Milewski D; Pradhan A; Wang X; Cai Y; Le T; Turpin B; Kalinichenko VV; Kalin TV
    Oncogene; 2017 Feb; 36(6):850-862. PubMed ID: 27425595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth.
    Yeung CL; Ngo VN; Grohar PJ; Arnaldez FI; Asante A; Wan X; Khan J; Hewitt SM; Khanna C; Staudt LM; Helman LJ
    Oncogene; 2013 Nov; 32(47):5429-38. PubMed ID: 23318429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERβ1 represses FOXM1 expression through targeting ERα to control cell proliferation in breast cancer.
    Horimoto Y; Hartman J; Millour J; Pollock S; Olmos Y; Ho KK; Coombes RC; Poutanen M; Mäkelä SI; El-Bahrawy M; Speirs V; Lam EW
    Am J Pathol; 2011 Sep; 179(3):1148-56. PubMed ID: 21763263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC.
    Nagel R; Stigter-van Walsum M; Buijze M; van den Berg J; van der Meulen IH; Hodzic J; Piersma SR; Pham TV; Jiménez CR; van Beusechem VW; Brakenhoff RH
    Mol Cancer Ther; 2015 Jun; 14(6):1434-44. PubMed ID: 25808837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell line.
    Mencalha AL; Binato R; Ferreira GM; Du Rocher B; Abdelhay E
    PLoS One; 2012; 7(10):e48160. PubMed ID: 23110199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis.
    Huang C; Qiu Z; Wang L; Peng Z; Jia Z; Logsdon CD; Le X; Wei D; Huang S; Xie K
    Cancer Res; 2012 Feb; 72(3):655-65. PubMed ID: 22194465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.
    de Olano N; Koo CY; Monteiro LJ; Pinto PH; Gomes AR; Aligue R; Lam EW
    Mol Cancer Res; 2012 Sep; 10(9):1189-202. PubMed ID: 22802261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.